Mohmmed Muqtader Ahmed

Pharmacology, Toxicology and Pharmaceutical Science

1. Nanoparticle 100%
2. Bioavailability 81%
3. Drug Release 78%
4. Chitosan 66%
5. Pharmacokinetic 64%
6. Sustained Release 57%
7. Cytotoxicity 56%
8. Breast Cancer 50%
9. Solid Lipid Nanoparticle 48%
10. Rat 47%
11. Lipid 44%
12. Drug Delivery System 43%
13. Zeta Potential 41%
14. Ethyl Cellulose 41%
15. Differential Scanning Calorimetry 39%
16. Tablet 36%
17. Scanning Electron Microscopy 33%
18. Apigenin 29%
19. Wound Healing 29%
20. Antioxidant Capacity 27%
21. Nanocarrier 26%
22. Non Small Cell Lung Cancer 25%
23. Amorphous Solid Dispersion 22%
24. Glycyrrhizin 22%
25. Baricitinib 22%
26. Apremilast 22%
27. Silver Nanoparticle 22%
28. Anti-Inflammatory Drug 22%
29. Antimicrobial Agent 21%
30. Diabetes Mellitus 20%
31. Phytochemical 19%
32. Rat Model 19%
33. Cyclodextrin 19%
34. Cyclodextrin 19%
35. Malignant Neoplasm 18%
36. Delafloxacin 18%
37. Polyvinyl Alcohol 17%
38. Acetic Acid Ethyl Ester 17%
39. Antiinfective Agent 16%
40. Erectile Dysfunction 16%
41. Tumor Necrosis Factor 16%
42. Polyglactin 15%
43. Antioxidant 15%
44. Lung Cancer 14%
45. Osimertinib 14%
46. Diosmin 14%
47. Olaparib 14%
48. Agents Acting on the Eye 14%
49. Tadalafil 14%
50. Sildenafil 14%